LVOQX
Price
$17.28
Change
-$0.16 (-0.92%)
Updated
Oct 9 closing price
Net Assets
1.13B
VEXMX
Price
$160.59
Change
-$0.96 (-0.59%)
Updated
Oct 9 closing price
Net Assets
83.66B
Interact to see
Advertisement

LVOQX vs VEXMX

Header iconLVOQX vs VEXMX Comparison
Open Charts LVOQX vs VEXMXBanner chart's image
Lord Abbett Value Opportunities R2
Price$17.28
Change-$0.16 (-0.92%)
VolumeN/A
Net Assets1.13B
Vanguard Extended Market Index Investor
Price$160.59
Change-$0.96 (-0.59%)
VolumeN/A
Net Assets83.66B
LVOQX vs VEXMX Comparison Chart in %
View a ticker or compare two or three
VS
LVOQX vs. VEXMX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOQX is a Buy and VEXMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 83.7B vs. LVOQX (1.13B). VEXMX pays higher dividends than LVOQX: VEXMX (0.97) vs LVOQX (0.00). LVOQX was incepted earlier than VEXMX: LVOQX (18 years) vs VEXMX (38 years). LVOQX (1.54) is less costly to investors than VEXMX (0.19). LVOQX is a more actively managed with annual turnover of: 33.00 vs. VEXMX (11.00). LVOQX has a lower initial minimum investment than VEXMX: LVOQX (0) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 17.33 vs. LVOQX (-7.04). VEXMX return over 5 years is better than : 55.00 vs. LVOQX (3.26).
LVOQXVEXMXLVOQX / VEXMX
Total Expense Ratio1.540.19811%
Annual Report Gross Expense Ratio1.540.19811%
Fund Existence18 years38 years-
Gain YTD0.46112.2434%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B83.7B1%
Annual Yield % from dividends0.000.97-
Returns for 1 year-7.0417.33-41%
Returns for 3 years17.3666.4926%
Returns for 5 years3.2655.006%
Returns for 10 years-8.85156.17-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEPG5.030.16
+3.29%
PepGen
IPSC0.600.01
+2.31%
Century Therapeutics
LOAR79.400.38
+0.48%
Loar Holdings
AZTA31.73-0.50
-1.55%
Azenta
AAPL254.04-4.02
-1.56%
Apple